Sweating The Small Stuff: Bruce Shibuya Wins Toyota Executive Management Award For Attention To Detail

Bruce K. Shibuya

THOUSAND OAKS, CA, UNITED STATES, September 30, 2020 /EINPresswire.com/ — Well-known as a leader at Toyota, Bruce Shibuya is known for his great attention to detail. Sweating the small stuff comes naturally to Bruce Shibuya, and high-level management has taken notice, awarding Shibuya with an executive management award for attention to detail.

Bruce Shibuya has long been known as an asset to Toyota, Kia, and Hyundai. His ability to see the big picture while also focusing on the small, day to day details that make programs work has been heralded as nothing short of industry-changing.

After getting his start as a product quality engineer with Toyota, Bruce Shibuya has slowly but steadily climbed the corporate ladder in the automotive industry. When Toyota saw a slip in their luxury brand's ranking from J.D. Power & Associates, Bruce Shibuya put in the tough, detail-oriented work necessary to reclaim the number one spot. During this time, Bruce Shibuya also managed all of the quality assurance aspects of the Toyota brand in the United States, working closely with engineers and developers to ensure that they were turning out top-notch products.

Over time, Bruce Shibuya moved from Toyota to Hyundai/ Kia and brought his reputation for excellence and attention to detail with him. He led introductions, quality operations, and product development for the creation of the Hyundai Sonata in the United States. Over three years, he was able to reduce warranty costs by $21 million due to his commitment to paying attention to every detail of the manufacturing process. By paying close attention to user issues, Bruce Shibuya is able to make the small but significant changes necessary to improve user experience, saving money long term.

At various semiconductor companies like NVIDIA and Jabil, Bruce Shibuya continues to show his stellar attention to detail, as he is in control of quality assurance and quality control. As Bruce Shibuya continues to change the game in the engineering and automotive industries. Shibuya is known as a leader amongst his peers, staying on top of innovation, and creating the standard for others when it comes to paying attention to detail.

It's clear that Bruce Shibuya's career trajectory is on the rise, and it's likely that he'll continue to be recognized for his attention to quality control. He continually puts in the hard work necessary to make products better, and he focuses on user experience to both create a better product quality for the user and to save the company money. Bruce Shibuya is in high demand in the engineering industry right now, and for good reason. Wherever Bruce Shibuya goes, quality follows, and he's proven that time and again.

Caroline Hunter
Web Presence, LLC
email us here

Source: EIN Presswire

Sombudha Adhikari Analyzes Cyber Security During Covid

Sombudha Adhikari

WHITEHOUSE STATION, NJ, UNITED STATES, September 30, 2020 /EINPresswire.com/ — Cybersecurity is a significant concern during the Covid pandemic because so many businesses are adapting to a stay-at-home work situation. This process often leaves their computers exposed to greater danger due to a lack of proper protection and training. As a result, Sombudha Adhikari recently discussed the methods you can use to keep your remote work squad safe.

Cybersecurity Challenges During Covid-19, As Examined By Sombudha Adhikari
As Covid-19 spreads and forces businesses to adapt, Sombudha Adhikari sees a lot of potential cybersecurity issues. First of all, working remotely opens up a business to many problems. For example, employees may not have the type of robust security available at a company's facility, causing them to be open to more potential hacking dangers.

This factor is particularly true when many video conferencing software options. Sombudha Adhikari has heard of unwanted visitors sneaking into these meetings and using information against businesses in many ways. Beyond these concerns, though, lie troubles with trader surveillance – including monitoring their calls and communication methods – and a high risk of scams.

It might seem hard to believe, but Sombudha Adhikari has noted that many at-home workers are prone to scams from potential clients or other hustlers. This problem can occur in all types of businesses and requires detailed solutions to keep a company safe.

Cybersecurity Solutions Defined by Sombudha Adhikari
The main trigger behind these cybersecurity issues, Sombudha Adhikari says, is the move to a more remote at-home work situation. By spreading out employees in this way, a company opens itself up to more potential attacks. But with Covid-19 still rampaging, working in a central location is dangerous. Thankfully, there are ways to avoid this issue.

First of all, a good VPN subscription is essential. These services hide a person's computer location and make hacking much harder. Sombudha Adhikari states that many VPN companies have business-based plans that can be used to protect many computers.

And Sombudha Adhikari also suggests installing robust anti-malware software onto all computers used in a network. This software helps to keep viruses and other harmful programs off your system. Sombudha Adhikari also suggests specialized anti-fraud training. This process helps your employees better spot potential scams and to know where to report them if they do occur. Online training modules of this type are available in many different forms and should be a given during these difficult times, he says.

About Sombudha Adhikari
As a Stanford University graduate in Data Science, Sombudha Adhikari has 20 years of experience creating detailed artificial intelligence programs for major corporations. He has won the Silicon Valley Innovation Award and is one of the most trusted innovators. Beyond that, he also predicted every significant economic downturn of the last 35 years and has created data analytic software that helps track financial changes throughout the market.

Caroline Hunter
Web Presence, LLC
+1 786-233-8220
email us here

Source: EIN Presswire

VERI Nano, Inc. Selected to Compete in 2020 MassChallenge Finals

VERI Nano, Inc. was selected today as one of the top 20 startups of the MassChallenge Accelerator Program in Boston.

BOSTON, MASSACHUSETTS, UNITED STATES, September 30, 2020 /EINPresswire.com/ — VERI Nano, Inc. was selected today as one of the top 20 startups of the MassChallenge Accelerator Program in Boston. Veri Nano will now participate in a final round of judging, along with 20 other startups, where they will compete for up to $1,000,000 in equity-free cash prizes. The prize winners will be announced on Thursday, October 22, 2020, as part of the 2020 MassChallenge Virtual U.S. Awards, which will livestream on the MassChallenge website.

Veri Nano, a bionanotechnology company composed of world-renowned experts, innovators, and serial entrepreneurs trained at Harvard Medical School and Massachusetts Institute of Technology (MIT), is using nanotechnology to provide solutions to different problems in numerous markets such as human and animal health, cosmetics, agriculture and food. The startup was selected based on its novel approach to prevent bovine mastitis.

“This year has been remarkable for our startups, to say the least. Nevertheless, in the face of a pandemic and an economic crisis, our startups demonstrated the resiliency, creativity, and relentless perseverance to launch their new ventures,” said Cait Brumme, Managing Director of MassChallenge Boston. “Across the board, our startups leveraged MassChallenge’s resources to hit critical milestones including securing first customers, raising funding, and growing teams. When successful, these startups will not only solve critical challenges but support job growth and recovery. We are proud that our community has come together in an unprecedented form to carry these startups forward.”
In response to the COVID-19 pandemic, the 100-early-stage startups from around the world participated in a completely virtual 2020 MassChallenge Boston accelerator.
During the four-month program, the startups leveraged expert mentorship, tailored curriculum, and the MC global network to launch and grow their companies. With more than a decade of experience, MassChallenge’s proven zero-equity model and global network works for its startups – not against them – by providing the vital resources they need to grow without taking any equity in return.
“We had a great experience during our time with Mass Challenge and due to that experience, VERI Nano continues to demonstrate the innovation and vision of our world-class team. We are very thankful for all the support from MassChallenge, as we have met so many great cohort teams, Mass Challenge employees, investors, and potential advisors along the way, while also learning and having a lot of fun”, said Cofounder Guillermo Ruiz-Esparaza, MD, PhD, FRSA.“ We are beyond excited and honored to be selected to the finals and to take our company to the next level.”

MassChallenge is hosting its first-ever virtual celebration of innovation and creativity featuring 200+ startups from the 2020 accelerator programs in Austin, Boston, Houston, and Rhode Island. The event will showcase the progress the startups have made during their program, feature industry-leading speakers Arianna Huffington (Thrive Global), Linda Pizzuti Henry (Boston Globe Media Partners), and Chris Denson (Innovation Crush) to speak on the transformative power of startups, and award up to $2M in equity-free cash prizes to the top startups from the programs.

MassChallenge is the global network for innovators. Headquartered in the United States with seven locations worldwide, MassChallenge equips bold entrepreneurs to disrupt the status quo and to create meaningful change. Since launching in 2009, more than 2,400 MassChallenge alumni have raised more than $6.2B in funding, generated more than $3B in revenue, and created more than 157,000 total jobs. Learn more about MassChallenge at masschallenge.org.

Veri Nano is an innovative bionanotechnology company emerged from world-renowned experts, innovators and serial entrepreneurs trained at Harvard Medical School and MIT. We are creating the future by designing novel nanotechnologies that could be applied to multiple industries. By using different types of biomaterials as building blocks, we have fabricated diverse types of novel systems such as nanoengineered hydrogels, nanosized molecular delivery systems, and nanocomposite materials. The startup was selected based on its novel approach to treat bovine mastitis.

Lauren Fish
+1 857-222-7477
email us here
Visit us on social media:

Source: EIN Presswire

Pharmaceutical Continuous Manufacturing Market to Reach 10.2% CAGR an Hit $854.8 Mn by 2026

Pharmaceutical Continuous Manufacturing Market

Continuous manufacturing is an advanced manufacturing approach with the potential to improve quality and consistency of medications with lower cost.

PUNE, MAHARASHTRA, INDIA, September 30, 2020 /EINPresswire.com/ — Rise in government support for continuous manufacturing adoption and increase in adoption of pharmaceutical continuous manufacturing systems fuel the growth of the global pharmaceutical continuous manufacturing market.

"Pharmaceutical Continuous Manufacturing Market by Product (Integrated Continuous Systems, Semicontinuous Systems, and Control & Software), Application (Final Drug Product Manufacturing and API Manufacturing), and End User (Pharmaceutical Companies, Contract Manufacturing Organizations, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026." According to the report, the global pharmaceutical continuous manufacturing industry was valued at $393.0 million in 2018, and is projected to reach $854.8 million by 2026, registering a CAGR of 10.2% from 2019 to 2026.

Download Free Sample Report with Detail COVID-19 Impact Analysis@ https://www.alliedmarketresearch.com/request-sample/6240

Pharmaceutical Continuous Manufacturing Market Competitive Analysis:

Leading market players Bosch Packaging Technology, Coperion GmbH, GEA Group AG, Gebrüder Lödige Maschinenbau GmbH, Glatt GmbH, Hosokawa Micron Corporation, Korsch AG, L.B. Bohle Maschinen + Verfahren GmbH, Munson Machinery Company, Inc., and Thermo Fisher Scientific Inc. Provided in this report. These players have adopted various strategies including expansions, mergers & acquisitions, joint ventures, new product launches, and collaborations to gain a strong position in the industry.

Drivers, restraints, and opportunities:

Rise in government support for continuous manufacturing adoption and increase in adoption of pharmaceutical continuous manufacturing systems fuel the growth of the global pharmaceutical continuous manufacturing market. However, poor demand from underdeveloped countries hinders the market growth. On the other hand, untapped potential from emerging countries create number of opportunities in the industry.

The integrated continuous systems segment to maintain its lead position during the forecast period:

Based on product, the integrated continuous systems segment contributed more than two-thirds of the total share of the global pharmaceutical continuous manufacturing market in 2018, and is expected to maintain its lead position during the forecast period. Moreover, this segment is expected to register the highest CAGR of 11.0% from 2019 to 2026. This is due to surge in adoption of integrated continuous manufacturing (ICM) process over the existing drug manufacturing processes, technological advancements, and availability of ICM systems. The research also analyzes the segment including semi-continuous systems and control or software.

The final drug product manufacturing segment to maintain its dominance in terms of revenue by 2026:

Based on application, the final drug product manufacturing segment held the highest market share of the global pharmaceutical continuous manufacturing market, contributing to nearly two-thirds of the total market share in 2018, and is expected to maintain its dominance in terms of revenue during the forecast period. This is due to surge in adoption of continuous manufacturing systems for production of final drugs, rise in number of pharmaceutical companies, and innovations in healthcare infrastructure. However, the API manufacturing segment is expected to register the highest CAGR of 11.7% from 2019 to 2026. This is due to rise in number of approved drugs produced by continuous processes.

North America to lead in terms of revenue during the forecast period:

Based on region, North America accounted for the largest market share in terms of revenue, contributing to more than one-third of the global pharmaceutical continuous manufacturing market in 2018, and is projected to lead in terms of revenue during the forecast period. This is due to presence of well-established infrastructure of the pharmaceutical industry, high adoption of advanced technologies, and wide availability of advanced pharmaceutical continuous manufacturing systems. However, Asia-Pacific is estimated to maintain the highest CAGR of 11.5% from 2019 to 2026, owing to growth in awareness regarding advanced pharmaceutical continuous manufacturing systems, surge in number of pharmaceutical companies, and increase in demand for continuous manufacturing systems in the region.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/6240

About Us:

Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises.


David Correa
Portland, OR, United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
Web: https://www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

Shadab Pathan
Allied Market Research
+1 800-792-5285
email us here

Source: EIN Presswire

Celebrity Dentist, Dr. Jay Grossman, Gives Thoughts On Cracked Teeth Epidemic in the U.S.

Dr. Jay Grossman

Conierge Dentistry

"The typical stress reducers are as important as ever especially when faced with a global crisis…"- Dr. Jay Grossman

LOS ANGELES, CA, US, September 30, 2020 /EINPresswire.com/ — A New York Times article revealed earlier this week that dentists are seeing an epidemic of cracked teeth. This peculiar increase has left some to speculate numerous reasons behind this epidemic. What’s really going on? One obvious answer as reported by the NY Times is stress. From COVID-induced nightmares to “doomsurfing” to “coronaphobia,” it’s no secret that pandemic-related anxiety is affecting our collective mental health. That stress, in turn, leads to clenching and grinding, which can damage the teeth. Dr. Jay Grossman, celebrity dentist and recent winner of the Best of Los Angeles Award – “Best Dentist – 2020” reveals his observations regarding the strange occurrences.

The current Professor at UCLA College of Dentistry, NYU College of Dentistry, and a former Professor at Western University College of Dental Medicine states, “The incidence of cracked teeth has grown exponentially during this pandemic, as reported in the New York Times and as validated in my own experience in my private practice. These times are very stressful on many people and as a result of stress many people grind and clench their teeth, which is known to crack teeth.”

Dr. Jay Grossman reminds folks the importance of being aware of this “para function”, and if you’re grinding, to get yourself fitted for a custom night guard at your dental office.

The NY Times article reveals that an unprecedented number of Americans are suddenly working from home, often wherever they can cobble together a makeshift workstation: on the sofa, perched on a barstool, tucked into a corner of the kitchen counter. The awkward body positions that ensue can cause us to hunch our shoulders forward, curving the spine into something resembling a C-shape. If you’re wondering why a dentist cares about ergonomics, the simple truth is that poor posture during the day can translate into a grinding problem at night. Dr. Jay Grossman concludes by reinstating the importance of a rested body during these changing times and difficult year. He states, “The typical stress reducers are as important as ever especially when faced with a global crisis; exercise yoga meditation and giving gratitude all help in reducing clenching and grinding as well as to help ensure a deeper and better night's sleep."

Dr. Jay Grossman (http://www.conciergedentistry.com) has a concierge dental practice in Brentwood, CA since 1991 with several specialists offering "continuity of care", all specialties under one roof. He is a graduate of NYU College of Dentistry as well as a former Lieutenant in the United States Navy Dental Corps. He is a current Professor at UCLA College of Dentistry, Professor at NYU College of Dentistry and a former Professor at Western University College of Dental Medicine. Dr. Grossman is a speaker on the national stage, and the founder of Homeless Not Toothless, an organization that has donated over $5 – Million in free dental care to over 60,000 homeless Veterans and foster children.

Dr. Jay Grossman and his Concierge Dentistry team’s goal has always been simple, to deliver the finest dental care available. Using state-of-the-art dental technology, they provide modern imaging capabilities that allow their patients to clearly see the reasons for procedures and the intended results. They recognize that patients are individuals with different goals and needs, and they strive to provide a soothing and educational environment where extraordinary results are realized.


Concierge Dentistry
11980 San Vicente Blvd #507
Los Angeles, CA 90049
(310) 820-0123

Homeless Not Toothless

Aurora DeRose
Boundless Media Inc.
+1 951-870-0099
email us here

Source: EIN Presswire

Digital Therapeutics Market in U.S. Like to Reach $5.08 Billion by 2027 at 19.2% CAGR

U.S. Digital Therapeutics Market

U.S. Digital Therapeutics Market

Rise in adoption of smart wearables with healthcare apps and surge in need to curb healthcare costs drive the growth of the U.S. digital therapeutics market

PORTLAND, OR , UNITED STATES, September 30, 2020 /EINPresswire.com/ — Allied Market Research published a report, titled, "U.S. Digital Therapeutics Market by Application (Diabetes, Obesity, Cardiovascular Disease (CVD), Central Nervous System (CNS) Disease, Respiratory Disease, Smoking Cessation, Gastrointestinal Disorder (GID), and Others), Product (Software and Device), and Sales Channel (Business-to-Business(B2B), Business-to-Consumer (B2C)): Opportunity Analysis and Industry Forecast, 2020–2027." According to the report, the U.S. digital therapeutics industry generated $1.16 billion in 2019, and is estimated to generate $5.08 billion by 2027, growing at a CAGR of 19.2% from 2020 to 2027.

Download Sample Report with Detailed COVID-19 Impact Analysis at: https://www.alliedmarketresearch.com/request-sample/7066

Drivers, restraints, and opportunities

Rise in adoption of tablets, smartphones, and smart wearables along with healthcare apps, surge in need to curb healthcare costs, and adoption of technologically advanced healthcare products & applications drive the growth of the U.S. digital therapeutics market. However, data privacy concerns and lack of proper reimbursement policies restrain the market growth. On the other hand, supportive laws and regulations for digital health technologies and surge in investments from market players create new opportunities in the coming years.

COVID-19 Scenario

There has been rise in awareness regarding digital health, avoidance of physical visits to clinics to reduce possibility of infection, and increase in mental health issues raised demand for digital therapeutics during the Covid-19 pandemic.
Digital therapeutics startups and leading players have been addressing conditions such as Type 2 diabetes, addiction, autism, and musculoskeletal injuries through video consultations, releasing instructional videos and blogs on their websites, and distributing healthcare programs through apps.
After receiving medications and treatments remotely, people have been ordering medication and medical devices through online channels.
"U.S. healthcare embraces digital therapeutics under the pressure of COVID-19 pandemic"

The diabetes segment to maintain its dominant position throughout the forecast period

Based on application, the diabetes segment held the highest market share in 2019, accounting for more than one-fourth of the U.S. digital therapeutics market, and is estimated to maintain its dominant position throughout the forecast period. This is attributed to high prevalence of diabetes and availability of cost-effective treatment options. However, the obesity segment is expected to witness the fastest CAGR of 22.1% from 2020 to 2027, owing to surge in number of overweight people and easy accessibility of digital therapeutics software applications to help patients in maintaining their proper diets and track physical activities.

The software segment to maintain its dominance by 2027

Based on product, the software segment accounted for more than two-thirds of the U.S. digital therapeutics market in 2019, and is estimated to maintain its dominance in terms of revenue by 2027. Moreover, this segment would portray the highest CAGR of 20.3% during the forecast period. This is attributed to increase in demand to lower healthcare costs and innovative software and apps containing advanced features that help people stay healthy and gain proper treatment. The research also analyzes the devices segment.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/7066

The business to business segment to continue its highest contribution by 2027

Based on sales channel, the business to business segment contributed to nearly two-thirds of the U.S. digital therapeutics market in 2019, and is projected to continue its highest contribution during the forecast period. This is due to rise in number of players in the industry that offer favorable reimbursement policies to employees through their employers in the U.S. However, the business to consumers segment is estimated to manifest the highest CAGR of 19.8% from 2020 to 2027, owing to ease in accessibility & availability of software and smart devices along with rise in demand of digital therapeutic products among patients and caregivers.

Leading market players

Fitbit, Inc. (Twine Health, Inc.)
Livongo Health, Inc.
Medtronic Plc.
Omada Health, Inc.
Pear Therapeutics, Inc.
Proteus Digital Health, Inc.
Resmed, Inc. (Propeller Health)
Voluntis, Inc.
Welldoc, Inc.
Access AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) at:

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter

Get more information: https://www.alliedmarketresearch.com/library-access

Similar Reports:

Phototherapy Apparatus Market – Global Opportunity Analysis and Industry Forecast, 2020–2027

Digital Pathology Market – Global Opportunity Analysis and Industry Forecast, 2019-2026

David Correa
Allied Analytics LLP
+1 800-792-5285
email us here
Visit us on social media:

Source: EIN Presswire

Artificial Intelligence In Diagnostics Market – Disruptive Global Pandemic Calls for Business Innovations

Global AI In Diagnostics Market was valued at USD 274 Mn in 2019 and is projected to touch USD 2424 Mn by 2027, rising at a CAGR of 31.5% from 2020 to 2027.

LEEDS, WEST YORKSHIRE, UNITED KINGDOM, September 30, 2020 /EINPresswire.com/ — Global AI In Diagnostics Market Analysis

Global AI In Diagnostics Market was valued at USD 274 Million in 2019 and is projected to touch USD 2424 Million by 2027, rising at a CAGR of 31.5% from 2020 to 2027.

Key components which are driving the market development include rising demand for lowering diagnostic cost, enhancing affected person care, lowering machine downtime coupled with rising demand for low-cost diagnostic techniques, efficient & environment friendly report analysis, and fast diagnostic information generation. Moreover, developments in AI and deep learning are anticipated to show extra efficient in figuring out illness analysis over the next few years.

Artificial intelligence (AI) refers to creation of distinctive techniques with the assistance of algorithms and software program that may carry out certain duties with out human intervention and instructions. Artificial intelligence includes integration of a number of applied sciences corresponding to machine learning, natural language processing, reasoning, and perception. AI is utilized in diagnostic for approximation of human cognition and evaluation of complicated medical and diagnostic imaging data. Artificial intelligence is primarily utilized in healthcare to research the connection between treatment methods and patient outcomes. AI applications are deployed in medical practices corresponding to diagnostic processes, drug growth, personalized medicines, and affected person monitoring care. For example, AI may assist in medical processes by checking the very important indicators, asking questions, and giving prescriptions to the patients. AI techniques may also be used for alerts and reminders, image interpretation, data retrieval, and remedy planning throughout medical procedures. Deep learning technology is used for image recognition, signal recognition, and data mining and is essentially the most extensively used type of AI technology.

Browse Report Description

Artificial Intelligence functions range from image acquisition, processing to aided reporting, follow-up plan, information storage, data mining, and others. Using machine learning incorporates computational models and algorithms that imitate the structure of the biological neural network in brain, i.e., artificial neural networks (ANNs). Performance wise Deep studying has greater efficiency rate in comparison with traditional machine learning.

Furthermore, AI has quite a few and numerous functions in medical diagnostics, corresponding to image evaluation for tumor detection, video detection for gait problems and fall prediction, biochemical checks corresponding to for diabetes or speech evaluation of emotional state and psychiatric problems. Due to this fact, AI will significantly disrupt the normal model of medical diagnosis.

Global AI In Diagnostics Market Overview

Rising number of government initiatives to encourage healthcare suppliers and different healthcare organizations to undertake AI-based diagnostic applied sciences and rising investments by nonprofit organizations and personal corporations to achieve higher information exchange improved scientific outcomes, and cost reductions are among the main components anticipated to drive the expansion of the marketplace for AI in diagnostics throughout the forecast interval. Furthermore, excessive demand for e-diagnostic providers within the healthcare sector because of increased authorities spending on healthcare is fueling market development.

Moreover, rising demand for lowering diagnostic prices, bettering patient care, and lowering machine downtime is among the components accelerating the utilization of artificial intelligence in diagnostics. Furthermore, rising demand for low-cost diagnostic strategies, efficient and efficient report evaluation, and fast diagnostic information era are few different components anticipated to drive the marketplace for AI in diagnostics. AI-powered gadgets are utilized in emergency medical procedures leading to lowering the time delay between trauma and analysis, thereby resulting in fast interventions and improved patient outcomes.

One other main factor fueling the market development at present is the adoption of this technology by a number of pharmaceutical and biotechnology corporations internationally to expedite vaccine or drug growth processes for COVID-19. Moreover, developments in AI and deep learning are anticipated to show extra efficient in figuring out illness analysis over the following few years.

Nonetheless, greater value for implementation of AI technologies, rise in safety issues, and government guidelines & regulations may hamper the overall market at a world level. Low healthcare access, and shortages of expert human assets are additionally anticipated to negatively affected the expansion within the historic interval.

Request Sample

Global AI In Diagnostics Market: Segmentation Analysis

Global AI In Diagnostics Market by Component

Primarily based on Component, the market is bifurcated into hardware, software and services. Software program section maintain largest share in AI in diagnostic market throughout forecast interval. Many corporations are creating software program options for numerous healthcare functions; that is the important thing issue complementing the expansion of the software program section. The rising demand for AI-powered and cloud-based augmented diagnostic options that assist in rising the diagnostic precision whereas deciphering medical images of a affected person is among the key components driving the section.

Global AI In Diagnostics Market by Technology

Primarily based on Technology, the market is bifurcated into Machine Learning, NLP, Context-Aware Computing, Computer Vision. Machine learning in AI diagnostics market projected to develop at highest CAGR throughout forecast interval. Rising adoption of deep studying in numerous healthcare functions, particularly within the areas of medical imaging, illness diagnostics, and drug discovery, and the usage of completely different sensors and gadgets to trace a affected person’s well being status in real time are supplementing the expansion of the market. Machine/deep learning with the Convolutional Neural Networks (CNNs) has not too long ago been gaining big consideration owing to its high-end efficiency in picture recognition.

Global AI In Diagnostics Market by Diagnosis Type

Primarily based on Diagnosis Type, the market is segmented into Radiology, Oncology, Neurology, Cardiology, Chest & Lungs, Pathology and Others. In 2019, neurology held a largest market share whereas radiology is predicted to be the quickest rising section over the forecast interval owing to the rising growth of AI-based software program available for diagnostic imaging. The neurology accounts for largest variety of regulatory approvals of the overall AI-based medical diagnostics platform.

Request Discount

Alex Jones
Research Report
+44 20 3769 3786
email us here

Source: EIN Presswire

Men’s Health Improves When Women Take Charge, Says Dr. David Samadi’s New Book

The Ultimate Manual available on Amazon

dr samadi in scrubs

What every woman should know about men’s health and how they can help

Women are the gatekeepers of our health. Majority of Healthcare decisions are made by women. The Ultimate Manual is a perfect book for women to buy and read in order to make their men healthy.”

— Dr. David Samadi

NEW YORK, NEW YORK, UNITED STATES, September 30, 2020 /EINPresswire.com/ — Dr. David Samadi, world-renowned urologic oncologist and robotic surgeon, has a relentless passion and ambition to improve men’s health – with the help of women. Tackling the tough topic of the decline of American men’s health, Dr. Samadi’s extensive medical expertise is showcased in his first book, The Ultimate MANual, Dr. Samadi’s Guide To Men’s Health and Wellness is now available online at both Amazon. One part of his book discusses why women are men’s best allies encouraging them to live more fulfilled healthier lives.
“Women are the gatekeepers of their families’ health,” explained Dr. Samadi. “Doctors depend on women to get men into our offices, addressing health concerns of their husbands, boyfriends, dads, and sons who often avoid or ignore these problems, until it’s too late. I highly respect women’s intelligence and insight and as men, we can learn a great deal from them.”
This book recognizes good health doesn’t just happen and women know this. Relying on personal responsibility, women anticipate the possibility of health issues. The book highlights women’s proactive, take charge attitude of living healthier lifestyles. In Dr. Samadi’s opinion, women are ideal for overseeing and encouraging men’s well-being too.
Dr. Samadi’s approach on women’s role in men’s health is simple. Recruit an army of women fired-up ready to mobilize the men they love to improve their health and well-being while increasing longevity at the same time.
The Ultimate MANual hits a homerun by devoting the first chapter talking specifically to women about the men they care about. It spells out why and how women can improve men’s health and better yet, why having healthy men in their lives benefits women too. Dr. Samadi provides pointers on beginning the not-so-easy but necessary conversations of convincing men to take care of themselves. Once this hurdle is passed, and men have adopted better health habits, they’ll experience the best health they’ve had in years.
Anyone wishing to learn more about Dr. David Samadi’s new book for interviews or other media appearances can contact him here:
Phone: 212-365-5000
Email: dsamadi@drsamadicenter.com
Dr. David Samadi is the Director of Men’s Health and Urologic Oncology at St. Francis Hospital in Long Island. He’s a renowned and highly successful board certified Urologic Oncologist Expert and Robotic Surgeon in New York City, regarded as one of the leading prostate surgeons in the U.S., with a vast expertise in prostate cancer treatment and Robotic-Assisted Laparoscopic Prostatectomy. Visit Dr. Samadi’s websites at robotic oncology and prostate cancer 911.

david b samadi
+1 2123655000
email us here
Visit us on social media:

men’s health and prostate health

Source: EIN Presswire

cmTriage and cmAssist by CureMetrix, a Finalist in Fast Company’s 2020 Innovation by Design Awards

CureMetrix is a Fast Company Innovation Finalist

CureMetrix Logo (CAD That Works)

CureMetrix AI joins 567 projects, products, and services from Spotify, Google, Disney+, and others.

It is our honor to be among the innovators recognized by Fast Company. With CureMetrix AI, we support doctors with data-driven information and tools to improve patient care”

— Navid Alipour, CEO, CureMetrix

LA JOLLA, CA, USA, September 30, 2020 /EINPresswire.com/ — CureMetrix was honored as a finalist in Fast Company’s Innovation by Design Awards for 2020 in the Health category.

The awards, which can be found in the October/November 2020 issue of Fast Company, recognize people, teams, and companies solving problems through design. One of the most sought-after design awards in the industry, Innovation by Design is the only competition to honor creative work at the intersection of design, business, and innovation.

cmTriage™ by CureMetrix is the first FDA-cleared AI-based triage solution for mammography in the U.S. It helps radiologists triage, sort and prioritize mammography worklists based on suspicious cases that may need immediate attention. Studies have shown that with cmTriage, radiologists can realize up to a 30% reduction in mammography reading time while supporting the overall practice to streamline workload.

CureMetrix is also conducting studies across the globe to expand its AI solutions to help identify, mark and score anomalies in breast cancer screening. In studies published in the Journal of Digital Imaging, CureMetrix cmAssist® AI-CAD was able to demonstrate the ability to reduce false positives by 69% over traditional CAD and help radiologists improve their breast cancer detection rate on average 27%, without increasing recall rates.

“We need innovative design more than ever, and the 2020 honorees have brought creativity, inventiveness, and humanity to address some of the world’s most pressing problems, including the global pandemic, racial injustice, and economic inequality. Together these entries offer a glimpse into a future that is more inclusive, more accessible, and more just,” said Stephanie Mehta, editor-in-chief of Fast Company.

“It is our honor to be among the innovators recognized by Fast Company. With CureMetrix AI, we support doctors with data-driven information and tools to improve patient care,” said Navid Alipour, chief executive officer of CureMetrix.

Honorees for the 2020 awards were selected in the following categories: Apps and Games; Cities; Data Design; Experimental; Fashion and Beauty; Finance; General Excellence; Graphic Design; Health; Home; Hospitality; Learning; Mobility; Packaging; Products; Retail Environments; Social Good; Spaces and Places; Sports and Recreation; Students; Sustainability; User Experience; Wellness; Workplace; Best Design Asia-Pacific; Best Design Europe, Best Design Middle East, and Best Design Africa; Best Design Latin America; and Best Design North America. Fast Company is also recognizing Newlab as the title’s third annual Design Company of the Year for its socially oriented tech manufacturing.

The judges include renowned designers from a variety of disciplines, business leaders from some of the most innovative companies in the world, and Fast Company’s own writers and editors. Entries are judged on the key ingredients of innovation: functionality, originality, beauty, sustainability, user insight, cultural impact, and business impact.

Winners, finalists, and honorable mentions are featured online and in the October/November issue of Fast Company magazine, on newsstands October 20.

To see the complete list, go to: https://www.fastcompany.com/innovation-by-design/2020

To see the most innovative health projects of 2020, go to: https://www.fastcompany.com/90547947/health-innovation-by-design-2020

Delivering CAD that Works®, CureMetrix is a global leader in artificial intelligence (AI) for medical imaging, committed to the advancement of technology that improves cancer survival rates worldwide. CureMetrix supports the radiologist to dramatically improve the accuracy of detection and classification of anomalies in mammography. Our mission is to save lives and support better clinical and financial outcomes. www.CureMetrix.com

Fast Company is the only media brand fully dedicated to the vital intersection of business, innovation, and design, engaging the most influential leaders, companies, and thinkers on the future of business. The editor-in-chief is Stephanie Mehta. Headquartered in New York City, Fast Company is published by Mansueto Ventures LLC, along with our sister publication, Inc., and can be found online at fastcompany.com.

Media Contact: Dawn Anderson
+1 858-345-6061
email us here
Visit us on social media:

Source: EIN Presswire

NEW Mailing List Website Has RED HOT CBD OIL Product Buyers Lists & Leads. Ramp Up Your CBD Oil Store or CBD Site Today

CBD OIL Consumers Mailing Lists

CBD OIL Buyers EMAIL Lists & Telephone Lists

This is what is happening now in the CBD market as it bursts out of the gates into a NEW emerging BILLION dollar industry. Fill your store – website with buyer

LAS VEGAS, NV, US, September 30, 2020 /EINPresswire.com/ — Las Vegas, Nevada, (Sept 30, 2020) Sprint Data Solutions Worldwide Marketing is here to help businesses emerging in the CBD & Marijuana industry to get in touch with the consumers and companies that can grow their sales. Clients have the opportunity to do B2B & B2C marketing with consumer and business postal mailing lists that can provide channels for sale and distribution through other outlets or consumers direct. Fill your local store or website with new customers today! The major players in CBD are onboard with Sprint Data Solutions Worldwide Marketing! Get your piece of the CBD market immediately.

However, for companies that prefer to communicate directly with customers, a consumer postal mailing list is also available for mass-market strategies. Sprint Data Solutions Worldwide Marketing has both the B2B and direct-to-consumer databases to help any business grow sales and operations.

Sprint Data Solutions Worldwide Marketing & Its Story. The nations CBD Marketing Godzilla with entire CBD databases of BUYERS not tire kickers. Completely certified by the USPS for accuracy.

Sprint Data Solutions Worldwide Marketing is a 100% American owned and operated business that started as a disabled veteran's dream. After completing duties to serving the country, the next move was to help the American business community, and the company steadily grew from that point on. The business now has a staff with over 50 years of combined industry experience in the marketing sector.

Sprint Data Solutions Worldwide Marketing focuses on helping businesses grow by finding the markets that need their products or services and facilitating connections. Before the widespread use of digital marketing, the company began working in the direct mail industry, which drove home the value of good data harvesting, management, and analytics. Those skills were easily transferred to the online era, as digital marketing became more important. It broadened the range of services the company could of-fer, from simple database provision to more intensive analytics-based services providing specificities such as ethnicity, mortgage acquisition, or donation behavior.

Today, Sprint Data Solutions Worldwide Marketing has increased its service scope far beyond its starting home of Las Vegas, Nevada. Coverage of services and database provision now accounts for the en-tire United States, including Alaska and Hawaii. The North American continent is also served, with databases available for countries like Mexico. Even service for countries across the Atlantic, like France, is available for people looking to expand into global markets.

The CBD Market

CBD stands for cannabidiol. It is one of several active substances found in the cannabis plant that is most famously associated with marijuana. THC, or tetrahydrocannabinol, is the active component of marijuana responsible for the "high" or psychedelic effects the narcotic is known for. However, CBD is the component in the marijuana experience that manages the calming effects and the reduction of pain. In other words, CBD does not make people "high" the usual sense, but it is useful for reducing stress and pain management.

As a result, in those areas where marijuana usage has been legalized, there is now an explosion in demand for the non-narcotic component, CBD. Medical marijuana and CBD had previously been prescribed for health reasons, but now, as states change their legislation, some states no longer require a prescription to consume CBD. It can be purchased and used similarly to over-the-counter painkillers, sleep aids, or digestive aids.

This has created a whole new demand for the product that is exploding everywhere that CBD can be easily acquired. It can be marketed primarily for these benefits:

Pain Management

CBD can be an effective pain reliever; however, unlike some prescription medication, such as opioids, it has no dramatic side-effects or a high degree of physical addictiveness. CBD has proven to be an effective treatment for chronic back pain, menstrual pain, and even treatment of animals' discomfort, such as dogs.

Cancer Treatment Symptom Relief

Some treatment methods, such as chemotherapy, bring with them a host of severe side-effects as they take the "scorched earth" approach to eradicating cancerous and healthy tissue. This can often lead to additional symptoms during treatment, such as pain, nausea, and vomiting. CBD is an effective method of reducing these symptoms without interfering with chemotherapy treatment.

Anxiety & Stress Reduction

As the component of the marijuana experience that is often attributed to the relaxation phase during consumption, CBD is now being actively researched and used on its own for stress management and even treating depression. Unlike some other medications, there appear to be no serious documented side-effects as of yet.

We Have The Databases

Sprint Data Solutions Worldwide Marketing has CBD oil buyer databases for any manufacturer looking for distribution channels or business looking direct access to customers. As CBD continues to be promoted by high-profile public figures like Oprah Winfrey, Dr. Phil, and even Alex Trebek, demand soars, and the industry needs more suppliers to reach a growing market.

Sprint Data Solutions Worldwide Marketing has a variety of different databases to help businesses reach their market. Whether you want to get in touch with retailers to sell your products or reach customers yourself, we have detailed lists of businesses and people with an active interest in CBD. The databases can be categorized according to geography metrics if you want to approach certain states, towns, or even specific postal codes. They can also be adjusted to demographic metrics such as income, ethnicity, and of course, interest in the product.

If you don't have any marketing experience, we even offer turnkey direct mail solutions that guide you through the entire process, under one roof. No need to talk to an ad agency for your concept, a printer for your manufacturing and printing and database service to reach your clientele; we can handle every step.

Patrick Trump
Sprint Data Solutions
+1 702-472-8668
email us here

Source: EIN Presswire